Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vardenafil in Men with Hypertension and Erectile Dysfunction
NCT00668005Phase 3Completed
- Sponsor
- Bayer
- Start
- Feb 2003
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in erectile dysfunction (ED) comparing Vardenafil with Placebo (2 arms). Primary endpoints: Sexual Encounter Profile Question 2 at 12 weeks and Sexual Encounter Profile Question 3 at 12 weeks. Started Feb 2003; status: completed.
02
Drugs
vardenafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT00668005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00668005.